Azenta ROE 2010-2025 | AZTA

Current and historical return on equity (ROE) values for Azenta (AZTA) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Azenta ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2025-03-31 $-0.07B $1.70B -3.62%
2024-12-31 $-0.16B $1.72B -8.41%
2024-09-30 $-0.17B $1.77B -7.83%
2024-06-30 $-0.16B $1.99B -6.83%
2024-03-31 $-0.15B $2.22B -6.09%
2023-12-31 $-0.02B $2.44B -0.72%
2023-09-30 $-0.01B $2.54B -0.51%
2023-06-30 $-0.04B $2.72B -1.28%
2023-03-31 $-0.05B $2.90B -1.50%
2022-12-31 $2.08B $2.87B 63.32%
2022-09-30 $2.13B $3.36B 73.37%
2022-06-30 $2.18B $3.43B 90.77%
2022-03-31 $2.22B $3.47B 119.17%
2021-12-31 $0.13B $1.37B 9.72%
2021-09-30 $0.11B $1.33B 8.62%
2021-06-30 $0.12B $1.31B 9.37%
2021-03-31 $0.09B $1.27B 7.58%
2020-12-31 $0.08B $1.25B 6.50%
2020-09-30 $0.07B $1.21B 5.52%
2020-06-30 $0.45B $1.18B 38.67%
2020-03-31 $0.44B $1.16B 42.03%
2019-12-31 $0.44B $1.16B 46.20%
2019-09-30 $0.44B $1.14B 52.26%
2019-06-30 $0.03B $0.74B 4.66%
2019-03-31 $0.05B $0.73B 6.92%
2018-12-31 $0.11B $0.73B 15.95%
2018-09-30 $0.12B $0.72B 16.84%
2018-06-30 $0.12B $0.71B 18.60%
2018-03-31 $0.12B $0.70B 18.56%
2017-12-31 $0.06B $0.63B 10.69%
2017-09-30 $0.06B $0.61B 10.68%
2017-06-30 $0.06B $0.59B 9.88%
2017-03-31 $0.05B $0.57B 8.64%
2016-12-31 $-0.05B $0.55B -9.14%
2016-09-30 $-0.07B $0.55B -12.24%
2016-06-30 $-0.07B $0.54B -12.52%
2016-03-31 $-0.07B $0.54B -12.23%
2015-12-31 $0.01B $0.62B 2.07%
2015-09-30 $0.02B $0.63B 2.38%
2015-06-30 $0.01B $0.63B 1.26%
2015-03-31 $0.02B $0.63B 3.75%
2014-12-31 $0.02B $0.63B 3.74%
2014-09-30 $0.03B $0.64B 4.67%
2014-06-30 $0.04B $0.66B 5.63%
2014-03-31 $0.01B $0.63B 2.22%
2013-12-31 $0.01B $0.63B 1.59%
2013-09-30 $0.00B $0.63B -0.32%
2013-06-30 $0.11B $0.62B 17.03%
2013-03-31 $0.11B $0.63B 18.70%
2012-12-31 $0.13B $0.64B 21.42%
2012-09-30 $0.14B $0.65B 24.77%
2012-06-30 $0.03B $0.53B 6.53%
2012-03-31 $0.09B $0.52B 17.97%
2011-12-31 $0.11B $0.52B 22.09%
2011-09-30 $0.13B $0.52B 27.50%
2011-06-30 $0.14B $0.51B 32.25%
2011-03-31 $0.09B $0.44B 22.93%
2010-12-31 $0.09B $0.41B 22.89%
2010-09-30 $0.06B $0.39B 17.03%
2010-06-30 $0.02B $0.36B 6.27%
2010-03-31 $-0.02B $0.34B -6.70%
2009-12-31 $-0.20B $0.32B -58.86%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $1.258B $0.656B
Azenta Inc. is a provider of life sciences solutions. The company provides reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the pharmaceutical, biotech, academic and healthcare institutions. Azenta Inc., formerly known as Brooks Automation Inc., is based in CHELMSFORD, Mass.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $38.234B 52.81
Hims & Hers Health (HIMS) United States $12.982B 134.88
Tempus AI (TEM) United States $10.012B 0.00
IRhythm Technologies (IRTC) United States $4.465B 0.00
Inspire Medical Systems (INSP) United States $4.309B 67.32
Privia Health (PRVA) United States $2.902B 198.33
Enovis (ENOV) United States $1.848B 10.30
Clover Health Investments (CLOV) United States $1.791B 0.00
Schrodinger (SDGR) United States $1.498B 0.00
Phreesia (PHR) United States $1.456B 0.00
Omnicell (OMCL) United States $1.281B 22.59
10x Genomics (TXG) United States $1.024B 0.00
Fulgent Genetics (FLGT) United States $0.618B 0.00
Butterfly Network (BFLY) United States $0.534B 0.00
Talkspace (TALK) United States $0.486B 145.25
Veradigm (MDRX) United States $0.476B 0.00
Claritev (CTEV) United States $0.473B 0.00
Standard BioTools (LAB) United States $0.395B 0.00
TruBridge (TBRG) United States $0.363B 805.00
Nyxoah SA (NYXH) Belgium $0.274B 0.00
Health Catalyst (HCAT) United States $0.260B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.195B 0.00
EUDA Health Holdings (EUDA) Singapore $0.141B 0.00
Pulmonx (LUNG) United States $0.126B 0.00
American Well (AMWL) United States $0.116B 0.00
MDxHealth SA (MDXH) Belgium $0.099B 0.00
CareCloud (CCLD) United States $0.086B 3.27
111 (YI) China $0.067B 0.00
Outset Medical (OM) United States $0.067B 0.00
P3 Health Partners (PIII) United States $0.056B 0.00
HeartBeam (BEAT) United States $0.053B 0.00
Retrieve Medical Holdings (RMHI) United States $0.051B 0.00
Zepp Health (ZEPP) Netherlands $0.038B 0.00
Zhongchao (ZCMD) China $0.033B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.022B 0.00
Bullfrog AI Holdings (BFRG) United States $0.017B 0.00
Precipio (PRPO) United States $0.015B 0.00
MSP Recovery (MSPR) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Streamline Health Solutions (STRM) United States $0.009B 0.00
Movano (MOVE) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00